IMPLANTERA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,138,090 | 1,270,852 | 1,630,155 | 2,327,208 | 2,883,437 | 3,076,199 | 3,220,008 | 3,123,116 |
| Profit before tax | 476,825 | 418,579 | 467,052 | 769,097 | 1,060,770 | 1,195,174 | 1,056,612 | 1,058,564 |
| Net profit | 406,253 | 356,033 | 381,953 | 739,419 | 953,441 | 1,052,731 | 927,907 | 897,721 |
| Equity | 1,312,921 | 1,648,498 | 1,732,261 | 1,721,680 | 1,615,119 | 1,717,850 | 1,645,758 | 1,539,285 |
| Liabilities | 209,252 | 158,778 | 403,082 | 308,924 | 385,578 | 268,027 | 155,176 | 163,005 |
| Non-current assets | 640,035 | 936,431 | 1,404,320 | 1,203,954 | 1,156,027 | 1,018,016 | 882,791 | 726,906 |
| Current assets | 882,138 | 870,845 | 730,493 | 826,042 | 843,299 | 966,742 | 917,147 | 974,274 |
| Total assets | 1,522,173 | 1,807,276 | 2,134,813 | 2,029,996 | 1,999,326 | 1,984,758 | 1,799,938 | 1,701,180 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 511,352 | 511,522 | 436,644 |
| Social insurance contributions | - | - | - | - | - | 161,245 | 181,739 | 174,809 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.1% | +11.7% | +28.3% | +42.8% | +23.9% | +6.7% | +4.7% | -3.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 26.7% | 19.7% | 17.9% | 36.4% | 47.7% | 53.0% | 51.6% | 52.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 30.9% | 21.6% | 22.0% | 42.9% | 59.0% | 61.3% | 56.4% | 58.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 35.7% | 28.0% | 23.4% | 31.8% | 33.1% | 34.2% | 28.8% | 28.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 41.9% | 32.9% | 28.7% | 33.0% | 36.8% | 38.9% | 32.8% | 33.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 92,278 | 100,995 | 74,098 | 77,790 | 92,270 | 87,268 | 85,298 | 81,473 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
IMPLANTERA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-27 | 2026-03-27 | 113.53 |
| 2026-03-17 | 2026-03-24 | 113.53 |
| 2026-02-18 | 2026-03-05 | 113.53 |
| 2026-01-16 | 2026-02-04 | 113.53 |
| 2025-07-24 | 2025-07-31 | 5.23 |
| 2025-07-16 | 2025-07-23 | 4.72 |
| 2025-06-17 | 2025-07-10 | 35.53 |
| 2025-06-11 | 2025-06-11 | 35.53 |
| 2025-06-08 | 2025-06-09 | 35.53 |
| 2025-05-16 | 2025-06-04 | 35.53 |
| 2022-04-25 | 2022-05-10 | 6.28 |
| 2022-02-18 | 2022-03-03 | 26.38 |
| 2021-12-30 | 2022-01-16 | 0.01 |
| 2021-12-16 | 2021-12-21 | 0.38 |
| 2021-10-18 | 2021-10-18 | 11016.41 |
| 2021-09-16 | 2021-09-19 | 11151.21 |
IMPLANTERA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-18 | 2026-02-21 | 289.26 |
| 2026-02-12 | 2026-02-17 | 560.26 |
| 2026-01-29 | 2026-02-11 | 0.19 |
| 2025-03-20 | 2025-03-20 | 171.33 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
IMPLANTERA, UAB (code 302551311) is a Private Limited Liability Company engaged in dental practice care activities. In the latest financial year 2025, the company generated revenue of €3.12M and net profit of €897.7K, with a profit margin of 28.7%. Revenue declined by 3.0% year on year, although it remained 1.5% above the 2023 level, showing a broadly stable two-year trajectory after the 2024 peak of €3.22M. Net profit also eased from €1.05M in 2023 and €927.9K in 2024 to €897.7K in 2025. The balance sheet remained solid, with total assets of €1.70M, equity of €1.54M and liabilities of €163.0K. The equity ratio stood at 90.5% and debt to equity at 0.11, indicating low leverage. Asset turnover was 1.84x, while return on equity was 58.3% and return on assets 52.8%. Revenue per employee reached €82.2K and profit per employee €23.6K, supporting the view of a productive, profitable business in 2025.